Binding of [3H]bryostatin 4 to protein kinase C

Nancy E. Lewin, Marie L. Dell'Aquila, George Pettit, Peter M. Blumberg, Barbour S. Warren

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The bryostatins represent a unique class of activators of protein kinase C (PKC) which induce only a subset of the responses typical of the phorbol esters and block those responses to the phorbol esters which they themselves do not induce. To better understand the interaction of the bryostatins with PKC, we have synthesized [26-3H]byrostatin 4 and characterized its binding to PKC. [3H]Bryostatin 4 and [3H]phorbol 12,13-dibutyrate ([3H]PDBu) differed markedly in their binding to PKC reconstituted with phosphatidylserine (PS). The binding affinity of [3H]bryostatin 4 under these conditions was too high to measure and the rate of release of bound bryostatin was much slower than that of the phorbol esters, with a half-time of several hours. These properties caused bryostatin 1 to appear to inhibit [3H]PDBu binding under these conditions in a non-competitive fashion. Both the high potency and the slow rate of release of the bryostatins may contribute to their unique pattern of biological activity. By reconstituting PKC in a mixture of 1.5% Triton X-100:0.3% PS, we were able to establish reversible conditions for [3H]bryostatin 4 binding. Under these conditions, binding of [3H]bryostatin 4 was competitively inhibited by PDBu, consistent with both the bryostatin and phorbol esters binding to PKC in a qualitatively similar fashion. Binding affinities to PKC isozymes α, β, and γ were compared and little difference was found, suggesting that differential recognition by these isozymes does not account for the unique biological activity of the bryostatins.

Original languageEnglish (US)
Pages (from-to)2007-2014
Number of pages8
JournalBiochemical Pharmacology
Volume43
Issue number9
DOIs
StatePublished - May 8 1992

Fingerprint

Bryostatins
Protein Kinase C
Phorbol Esters
Phosphatidylserines
Bioactivity
Isoenzymes
Carrier Proteins
Phorbol 12,13-Dibutyrate
Octoxynol
bryostatin 4

ASJC Scopus subject areas

  • Pharmacology

Cite this

Lewin, N. E., Dell'Aquila, M. L., Pettit, G., Blumberg, P. M., & Warren, B. S. (1992). Binding of [3H]bryostatin 4 to protein kinase C. Biochemical Pharmacology, 43(9), 2007-2014. https://doi.org/10.1016/0006-2952(92)90644-X

Binding of [3H]bryostatin 4 to protein kinase C. / Lewin, Nancy E.; Dell'Aquila, Marie L.; Pettit, George; Blumberg, Peter M.; Warren, Barbour S.

In: Biochemical Pharmacology, Vol. 43, No. 9, 08.05.1992, p. 2007-2014.

Research output: Contribution to journalArticle

Lewin, NE, Dell'Aquila, ML, Pettit, G, Blumberg, PM & Warren, BS 1992, 'Binding of [3H]bryostatin 4 to protein kinase C', Biochemical Pharmacology, vol. 43, no. 9, pp. 2007-2014. https://doi.org/10.1016/0006-2952(92)90644-X
Lewin, Nancy E. ; Dell'Aquila, Marie L. ; Pettit, George ; Blumberg, Peter M. ; Warren, Barbour S. / Binding of [3H]bryostatin 4 to protein kinase C. In: Biochemical Pharmacology. 1992 ; Vol. 43, No. 9. pp. 2007-2014.
@article{e6b614621d674cec95ee1c86cb715798,
title = "Binding of [3H]bryostatin 4 to protein kinase C",
abstract = "The bryostatins represent a unique class of activators of protein kinase C (PKC) which induce only a subset of the responses typical of the phorbol esters and block those responses to the phorbol esters which they themselves do not induce. To better understand the interaction of the bryostatins with PKC, we have synthesized [26-3H]byrostatin 4 and characterized its binding to PKC. [3H]Bryostatin 4 and [3H]phorbol 12,13-dibutyrate ([3H]PDBu) differed markedly in their binding to PKC reconstituted with phosphatidylserine (PS). The binding affinity of [3H]bryostatin 4 under these conditions was too high to measure and the rate of release of bound bryostatin was much slower than that of the phorbol esters, with a half-time of several hours. These properties caused bryostatin 1 to appear to inhibit [3H]PDBu binding under these conditions in a non-competitive fashion. Both the high potency and the slow rate of release of the bryostatins may contribute to their unique pattern of biological activity. By reconstituting PKC in a mixture of 1.5{\%} Triton X-100:0.3{\%} PS, we were able to establish reversible conditions for [3H]bryostatin 4 binding. Under these conditions, binding of [3H]bryostatin 4 was competitively inhibited by PDBu, consistent with both the bryostatin and phorbol esters binding to PKC in a qualitatively similar fashion. Binding affinities to PKC isozymes α, β, and γ were compared and little difference was found, suggesting that differential recognition by these isozymes does not account for the unique biological activity of the bryostatins.",
author = "Lewin, {Nancy E.} and Dell'Aquila, {Marie L.} and George Pettit and Blumberg, {Peter M.} and Warren, {Barbour S.}",
year = "1992",
month = "5",
day = "8",
doi = "10.1016/0006-2952(92)90644-X",
language = "English (US)",
volume = "43",
pages = "2007--2014",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Binding of [3H]bryostatin 4 to protein kinase C

AU - Lewin, Nancy E.

AU - Dell'Aquila, Marie L.

AU - Pettit, George

AU - Blumberg, Peter M.

AU - Warren, Barbour S.

PY - 1992/5/8

Y1 - 1992/5/8

N2 - The bryostatins represent a unique class of activators of protein kinase C (PKC) which induce only a subset of the responses typical of the phorbol esters and block those responses to the phorbol esters which they themselves do not induce. To better understand the interaction of the bryostatins with PKC, we have synthesized [26-3H]byrostatin 4 and characterized its binding to PKC. [3H]Bryostatin 4 and [3H]phorbol 12,13-dibutyrate ([3H]PDBu) differed markedly in their binding to PKC reconstituted with phosphatidylserine (PS). The binding affinity of [3H]bryostatin 4 under these conditions was too high to measure and the rate of release of bound bryostatin was much slower than that of the phorbol esters, with a half-time of several hours. These properties caused bryostatin 1 to appear to inhibit [3H]PDBu binding under these conditions in a non-competitive fashion. Both the high potency and the slow rate of release of the bryostatins may contribute to their unique pattern of biological activity. By reconstituting PKC in a mixture of 1.5% Triton X-100:0.3% PS, we were able to establish reversible conditions for [3H]bryostatin 4 binding. Under these conditions, binding of [3H]bryostatin 4 was competitively inhibited by PDBu, consistent with both the bryostatin and phorbol esters binding to PKC in a qualitatively similar fashion. Binding affinities to PKC isozymes α, β, and γ were compared and little difference was found, suggesting that differential recognition by these isozymes does not account for the unique biological activity of the bryostatins.

AB - The bryostatins represent a unique class of activators of protein kinase C (PKC) which induce only a subset of the responses typical of the phorbol esters and block those responses to the phorbol esters which they themselves do not induce. To better understand the interaction of the bryostatins with PKC, we have synthesized [26-3H]byrostatin 4 and characterized its binding to PKC. [3H]Bryostatin 4 and [3H]phorbol 12,13-dibutyrate ([3H]PDBu) differed markedly in their binding to PKC reconstituted with phosphatidylserine (PS). The binding affinity of [3H]bryostatin 4 under these conditions was too high to measure and the rate of release of bound bryostatin was much slower than that of the phorbol esters, with a half-time of several hours. These properties caused bryostatin 1 to appear to inhibit [3H]PDBu binding under these conditions in a non-competitive fashion. Both the high potency and the slow rate of release of the bryostatins may contribute to their unique pattern of biological activity. By reconstituting PKC in a mixture of 1.5% Triton X-100:0.3% PS, we were able to establish reversible conditions for [3H]bryostatin 4 binding. Under these conditions, binding of [3H]bryostatin 4 was competitively inhibited by PDBu, consistent with both the bryostatin and phorbol esters binding to PKC in a qualitatively similar fashion. Binding affinities to PKC isozymes α, β, and γ were compared and little difference was found, suggesting that differential recognition by these isozymes does not account for the unique biological activity of the bryostatins.

UR - http://www.scopus.com/inward/record.url?scp=0026612631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026612631&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(92)90644-X

DO - 10.1016/0006-2952(92)90644-X

M3 - Article

C2 - 1596288

AN - SCOPUS:0026612631

VL - 43

SP - 2007

EP - 2014

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 9

ER -